Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

86.4K
Overview
86.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymer Molecular Weight Influences Cancer Cell Surface Retention and Cytokine Presentation by Layer-by-Layer Nanoparticles.

ACS nano·2026
Same author

Vaccination elicits HIV broadly neutralizing antibodies in primates.

Nature·2026
Same author

Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies.

Nature·2026
Same author

Engineering drug-responsive replication machinery for precise control of self-amplifying RNA.

Nature biomedical engineering·2026
Same author

Rapid boosting increases germinal center responses to sequential vaccines.

Nature immunology·2026
Same author

Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery to lymph nodes enhance humoral immune responses.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Apr 1, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

630

Biomaterial Strategies for Immunomodulation.

Nathan A Hotaling1,2, Li Tang3,4,5,6, Darrell J Irvine3,4,5,6,7

  • 1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine.

Annual Review of Biomedical Engineering
|October 1, 2015
PubMed
Summary

Biomaterials offer new ways to control immune responses for applications in vaccines, cancer therapy, and autoimmune disease treatment. This review highlights advances in using biomaterials to precisely engineer the immune system for therapeutic benefit.

Keywords:
immunoengineeringimmunotherapyvaccination

More Related Videos

Biological Compatibility Profile on Biomaterials for Bone Regeneration
10:28

Biological Compatibility Profile on Biomaterials for Bone Regeneration

Published on: November 16, 2018

13.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Related Experiment Videos

Last Updated: Apr 1, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

630
Biological Compatibility Profile on Biomaterials for Bone Regeneration
10:28

Biological Compatibility Profile on Biomaterials for Bone Regeneration

Published on: November 16, 2018

13.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Area of Science:

  • Biomaterials Science
  • Immunology
  • Biomedical Engineering

Background:

  • Precise control over immune responses is crucial for developing effective vaccines, therapies for autoimmune diseases and cancer, and regenerative medicine.
  • The complexity of immune system signaling presents significant challenges in predictably manipulating immune responses for therapeutic purposes.

Purpose of the Study:

  • To review recent advancements in biomaterials designed for immunomodulation.
  • To explore how biomaterials can be engineered to control immune cell stimulation, differentiation, and organization.
  • To highlight the potential of biomaterials in targeting drugs and vaccines to specific immune sites.

Main Methods:

  • Review of current literature on biomaterials for immunomodulation.
  • Focus on design principles for controlled immunostimulation.
  • Analysis of biomaterial applications in drug/vaccine delivery and tissue engineering.

Main Results:

  • Biomaterials can be designed to control the timing, location, and nature of immune cell stimulation in vivo.
  • Biomaterials enable fine-tuning of immune cell differentiation in vitro.
  • Scaffolds made from biomaterials can organize immune cells and mimic lymphoid tissue structures.

Conclusions:

  • Biomaterials represent a powerful tool for engineering the immune system.
  • Advances in biomaterial design offer promising strategies for diverse biomedical applications, including immunotherapy and regenerative medicine.
  • Further development in this field holds potential for creating safer and more effective immune-based therapies.